| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/1998 | EP0835301A1 Human beta 2 integrin alpha subunit |
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835265A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835262A1 Method for the treatment of corticosteroid induced osteopenia |
| 04/15/1998 | EP0835260A1 Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis |
| 04/15/1998 | EP0835259A1 Iodine-containing peptides and their use as x-ray contrast media |
| 04/15/1998 | EP0835135A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0835129A1 Prevention of a disease having the characteristics of diabetes |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835127A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 04/15/1998 | EP0835126A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/15/1998 | EP0835125A1 Cd4-derived peptides that inhibit immune responses |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0835123A1 Aminopeptidase p inhibitors and uses thereof |
| 04/15/1998 | EP0835108A1 Use of lamellarin-class alkaloids in methods of treatment |
| 04/15/1998 | EP0835101A2 Method of producing sustained-release preparation |
| 04/15/1998 | EP0801655B1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 04/15/1998 | EP0772436A4 Incorporation of biologically active molecules into bioactive glasses |
| 04/15/1998 | EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 04/15/1998 | EP0674524B1 Stable lyophilized pharmaceutical preparations g-csf |
| 04/15/1998 | EP0667771B1 Antitumour compositions containing taxane derivatives |
| 04/15/1998 | EP0666749B1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 04/15/1998 | EP0650367A4 Blocking intercellular interactions with cd43 chimeric molecules. |
| 04/15/1998 | EP0640130B1 Chimeric multivalent protein analogues and methods of use thereof |
| 04/15/1998 | EP0515434B1 Method for treating intestinal diseases |
| 04/15/1998 | EP0460052B1 Il-1 biological activity inhibitors |
| 04/15/1998 | CN1179181A GnRH-leukotoxin chimeras |
| 04/15/1998 | CN1179180A RAGE tumer rejection antigens |
| 04/15/1998 | CN1179163A Gclq receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/15/1998 | CN1179107A Dried blood factor composition comprising trehalose |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1179105A Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 04/15/1998 | CN1178677A Luteotropic preparation for parturient women and its producing technology |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/14/1998 | US5739307 Cell growth factors |
| 04/14/1998 | US5739306 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
| 04/14/1998 | US5739290 Monoclonal antibody against an interferon-induced human protein in pure form |
| 04/14/1998 | US5739288 Fibrin sealant compositions |
| 04/14/1998 | US5739286 Mineralized intact collagen fibers; precipitated crystalline calcium phosphate |
| 04/14/1998 | US5739284 Compositions corresponding to a high-affinity glutamate transporter molecule and methods for making and using same |
| 04/14/1998 | US5739283 Prevention of invasive pulmonary aspergillosis with serine proteinase inhibitors |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739279 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents |
| 04/14/1998 | US5739276 Conotoxin peptides |
| 04/14/1998 | US5739274 Comprising polypeptide linked to phospholipid; produces delayed increase in blood pressure, increase in extracellular calcium uptake by vascular smooth muscle |
| 04/14/1998 | US5739272 Procedure for obtaining carbocalcitonin |
| 04/14/1998 | US5739162 Antagonist for gastrin and/or cholecystokinin b-not a-receptors; side effect reduction; antiulcer agents; opiod-enhancing analgesics; gastrointestinal disorders; anxiolytic agents |
| 04/14/1998 | US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
| 04/14/1998 | US5739129 Agonist activity |
| 04/14/1998 | US5739122 Dextran esters, the preparation thereof and the use thereof for coating or embedding drugs |
| 04/14/1998 | US5739119 Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 04/14/1998 | US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity |
| 04/14/1998 | US5739112 Anticoagulants |
| 04/14/1998 | US5739111 Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone |
| 04/14/1998 | US5739110 Protection of hemopoietic cells |
| 04/14/1998 | US5739109 Method of treating neuroinflammatory degenerative diseases |
| 04/14/1998 | US5739108 Nonaqueous composition comprising somatotropin polypeptide, biocompatible oil; sustained release |
| 04/14/1998 | US5739107 Morphogen treatment of gastrointestinal ulcers |
| 04/14/1998 | US5739106 Appetite regulating compositions |
| 04/14/1998 | US5739105 Immunosuppressive agents |
| 04/14/1998 | US5739104 Anti-fungal agents |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5739102 Wound healing |
| 04/14/1998 | US5739101 Administering an anticoagulants |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739012 Stable activator from genetically engineered cells |
| 04/14/1998 | US5739011 DNA for the production of multimeric hemoglobins |
| 04/14/1998 | US5739010 Human transcription factor |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5739008 DNA encoding a protein comprising calmodulin-and actin-binding human caldesmon peptide fragment |
| 04/14/1998 | US5739002 Providing reaction mixture comprising ns3 protease and substrate, adding candidate compound comprising fragment of hepatitis c virus ns4a protein, measuring protease activity to determine whether increase has occurred |
| 04/14/1998 | US5738991 Method of detecting elastase IV |
| 04/14/1998 | US5738985 Screening for potential antiviral agent by determining whether a potential antiviral agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus rna |
| 04/14/1998 | US5738984 Kits and methods of detection using cellulose binding domain fusion proteins |
| 04/14/1998 | US5738878 Purification, isolation by eluting with aqueous methanol solution; liquid chromatography |
| 04/14/1998 | US5738854 Genetic engineered mutant dna; veterinary medicine |
| 04/14/1998 | US5738849 Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| 04/14/1998 | US5738848 Immunosuppressive compounds and method of preparing same |
| 04/14/1998 | US5738846 Conjugating interferon to polymer strand having one or both ends activated by carbamate-or amide-forming groups |
| 04/14/1998 | US5738845 Human interferon τ proteins and methods of use |
| 04/14/1998 | US5738844 Polypeptides |
| 04/14/1998 | US5738838 Metal ion-binding domains are labeled with medically useful metal ions for lung imaging |
| 04/14/1998 | US5738784 Device for separating a blood component from blood or plasma |
| 04/14/1998 | CA2116691C Plasma fraction purification |
| 04/14/1998 | CA1339815C Modified factor vii/viia |
| 04/14/1998 | CA1339814C Pharmaceutical formulations |
| 04/09/1998 | WO1998014615A1 Antisense oligonucleotide modulation of mdr p-glycoprotein gene expression |
| 04/09/1998 | WO1998014606A1 Method for diminishing myocardial infarction using protein phosphatase inhibitors |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014587A1 Inhibition of hiv replication using soluble tat peptide analogs |